In for the long-haul? Seropositivity and sequelae 1 year post COVID-19
Autor: | Jeremy W. Deuel, Patricia Schlagenhauf |
---|---|
Přispěvatelé: | Deuel, Jeremy Werner [0000-0002-5409-7712], Apollo - University of Cambridge Repository, University of Zurich, Deuel, Jeremy Werner |
Rok vydání: | 2021 |
Předmět: |
Adult
2019-20 coronavirus outbreak COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) Health Personnel Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 610 Medicine & health 2700 General Medicine Antibodies Viral Cohort Studies Seroepidemiologic Studies Humans Medicine Prospective Studies SARS-CoV-2 business.industry Disease progression COVID-19 10060 Epidemiology Biostatistics and Prevention Institute (EBPI) Long-COVID General Medicine Middle Aged Virology Cross-Sectional Studies Spain Reinfection Commentary Disease Progression Female business |
Zdroj: | BMC Medicine, Vol 19, Iss 1, Pp 1-2 (2021) BMC Medicine |
ISSN: | 1741-7015 |
Popis: | We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149-270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not yet been vaccinated by April 2021, seropositivity was 96.88% (95.31% IgG, 82.81% IgA) up to 322-379 days post symptoms onset. Four suspected reinfections were detected by passive case detection, two among seronegative individuals (5 and 7 months after the first episode), and one low antibody responder. Antibody levels significantly correlated with fever, hospitalization, anosmia/hypogeusia, allergies, smoking, and occupation. Stable sustainment of IgG responses raises hope for long-lasting COVID-19 vaccine immunity. |
Databáze: | OpenAIRE |
Externí odkaz: |